胜肽合成市场规模、份额、成长分析、按产品、按技术、按应用、按最终用途、按地区 - 产业预测，2024-2031 年

2022年全球胜肽合成市场规模预计为6.1956亿美元，预测期内（2024-2031年）复合年增长率为13.0%，从2023年的7.0111亿美元增至2031年的180万美元。 6120万美元。

由于对肽类疗法的需求不断增加，全球肽合成市场正在显着成长。胜肽作为控制各种生理功能和代谢过程的信号分子，与传统的小分子药物和生技药品相比，具有改善的代谢稳定性、高靶点特异性和强结合亲和性，近年来受到人们的关注。特别是，全球已有80多种胜肽疗法已被核准用于治疗癌症、糖尿病和爱滋病毒等慢性疾病，并且自2015年以来已经进行了630多项临床试验来评估其治疗效果。基于胜肽的诊断和治疗剂的激增，尤其是在大流行之后，反映出人们对胜肽合成作为现代医学的重要组成部分日益增长的兴趣。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析

全球胜肽合成市场规模：依产品/服务/复合年增长率（2024-2031）

• 试剂
  • 树脂
  • 胺基酸
  • 耦合试剂
  • 染料/萤光标记试剂
  • 其他试剂
• 装置
  • 胜肽合成仪
  • 层析法设备
  • 冷冻干燥机
• 服务

胜肽合成市场规模：依技术及复合年增长率（2024-2031）

• 固相胜肽合成
• 液相胜肽合成
• 混合/重组技术

胜肽合成市场规模：最终用户的复合年增长率（2024-2031）

• 製药和生物技术公司
• CDMO・CRO
• 学术/研究机构

胜肽合成市场规模/复合年增长率（2024-2031）

• 北美（产品/服务、技术、最终用户）
  • 美国
  • 加拿大
• 欧洲（产品/服务、技术、最终用户）
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区（产品/服务、技术、最终用户）
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲（产品/服务、技术、最终用户）
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲（产品/服务、技术、最终用户）
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按公司分公司分類的股份分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• MERCK KGAA
• THERMO FISHER SCIENTIFIC
• GENSCRIPT BIOTECH CORPORATION
• BACHEM HOLDING AG
• KANEKA CORPORATION
• BIOTAGE AB
• SYNGENE INTERNATIONAL LIMITED
• MESA LABORATORIES, INC.
• CEM CORPORATION
• PROTEOGENIX
• BIO-SYNTHESIS INC.
• DALTON PHARMA SERVICES
• AAPPTEC
• VIVITIDE
• ANYGEN CO., LTD.
• ADVANCED CHEMTECH
• LUXEMBOURG BIO TECHNOLOGIES LTD.
• JPT PEPTIDE TECHNOLOGIES GMBH
• AMBIOPHARM INC.
• AURIGENE PHARMACEUTICAL SERVICES LTD.

结论和建议

Global Peptide Synthesis Market size was valued at USD 619.56 million in 2022 and is poised to grow from USD 700.11 million in 2023 to USD 1861.20 million by 2031, growing at a CAGR of 13.0% during the forecast period (2024-2031).

The global peptide synthesis market has experienced significant growth driven by the increasing demand for peptide-based therapeutics. Peptides, which act as signaling molecules that regulate various physiological functions and metabolic processes, have gained traction in recent years due to their improved metabolic stability, target specificity, and stronger binding affinity compared to traditional small molecule drugs and biologics. Notably, over 80 peptide therapeutics have been approved globally for treating chronic conditions such as cancer, diabetes, and HIV, with more than 630 clinical trials conducted since 2015 to evaluate their therapeutic efficacy. The surge in peptide-based diagnostics and therapies, especially post-pandemic, reflects growing interest in peptide synthesis as an essential component of modern medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peptide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peptide Synthesis Market Segmental Analysis

Global Peptide Synthesis Market is segmented by Product & Services, Technology, end user and region. Based on Product & Services, the market is segmented into Reagents, Equipment, Services. Based on Technology, the market is segmented into Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology. Based on end user, the market is segmented into Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Peptide Synthesis Market

The growing demand for imaging technology to enable accurate diagnosis of chronic diseases is a significant driver for the global peptide synthesis market. Valued at over USD 30 billion in 2023, the peptide synthesis market is benefiting from the increasing use of peptide-based biosensors and biomarkers, both in invasive and non-invasive diagnostic applications. These advanced diagnostic tools are witnessing substantial demand, as they provide critical insights into various health conditions. The rise in healthcare applications for peptide-based biosensors, along with their ability to enhance disease detection and monitoring, is fueling market growth and creating new opportunities for peptide synthesis technologies. This trend is expected to continue driving market expansion in the coming years.

Restraints in the Global Peptide Synthesis Market

A significant restraint in the global peptide synthesis market is the reliance on contract manufacturing organizations (CMOs) for peptide production. Pharmaceutical companies are investing heavily in the development of peptide-based therapeutics, but the manufacturing process is mostly outsourced to CMOs, which are typically located in developed economies due to lower production costs. This reliance on external manufacturers can lead to challenges in maintaining strict adherence to standardization guidelines and safety standards, potentially affecting the consistency and quality of peptide products. Additionally, the limited control over the manufacturing process can introduce risks related to regulatory compliance, further constraining market growth.

Market Trends of the Global Peptide Synthesis Market

A key trend in the global peptide synthesis market is the steady rise in demand from the pharmaceutical industry, driven by increased research and development (R&D) investments. The pharmaceutical sector is witnessing significant growth, with R&D spending growing even faster. According to a 2020 survey by the US Census Bureau, pharmaceutical R&D expenditure has surged by over 25% over the past decade, reflecting a growing commitment to innovation. This trend is enhancing the funding available for the development of advanced peptide synthesis solutions and processes, further driving market growth. The surge in pharmaceutical R&D budgets is expected to continue fostering advancements in peptide synthesis technologies, expanding their applications and market opportunities.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis

Global Peptide Synthesis Market Size by Product & Service & CAGR (2024-2031)

• Reagents
  • Resins
  • Amino acids
  • Coupling Reagents
  • Dyes and Fluorescent labeling reagents
  • Other Reagents
• Equipment
  • Peptide Synthesizers
  • Chromatography Equipment
  • Lyophiizers
• Services

Global Peptide Synthesis Market Size by Technology & CAGR (2024-2031)

• Solid-Phase Peptide Synthesis
• Solution-Phase Peptide Synthesis
• Hybrid & Recombinant Technology

Global Peptide Synthesis Market Size by End User & CAGR (2024-2031)

• Pharmaceutical & Biotechnology companies
• CDMOs & CROs
• Academic & Research Institutes

Global Peptide Synthesis Market Size & CAGR (2024-2031)

• North America, (Product & Services, Technology, End User)
  • US
  • Canada
• Europe, (Product & Services, Technology, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Services, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Services, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Services, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• MERCK KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THERMO FISHER SCIENTIFIC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSCRIPT BIOTECH CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BACHEM HOLDING AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KANEKA CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTAGE AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNGENE INTERNATIONAL LIMITED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MESA LABORATORIES, INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEM CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PROTEOGENIX
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIO-SYNTHESIS INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DALTON PHARMA SERVICES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AAPPTEC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVITIDE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANYGEN CO., LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADVANCED CHEMTECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LUXEMBOURG BIO TECHNOLOGIES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JPT PEPTIDE TECHNOLOGIES GMBH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMBIOPHARM INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AURIGENE PHARMACEUTICAL SERVICES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation